Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome

Yuanqi Li, Yong TanComput. Math. Methods Medicine 2021 · DOI

TL;DR

This study uses bioinformatics to construct a complex network of long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) to understand the molecular underpinnings of Polycystic Ovary Syndrome (PCOS). By identifying key lncRNAs within this network, the research proposes potential new biomarkers and therapeutic targets for this common endocrine disorder.

What Problem Does This Paper Address?

Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, characterized by hormonal imbalances, metabolic dysfunction, and often leading to infertility. Despite its widespread impact, the precise molecular mechanisms driving PCOS remain incompletely understood, hindering the development of effective treatments. While long non-coding RNAs (lncRNAs) have emerged as crucial regulators in various biological processes, including cancer, their specific roles in PCOS pathogenesis are still being explored. This paper aims to fill this knowledge gap by investigating the intricate regulatory interactions within PCOS at the molecular level, focusing on the competitive endogenous RNA (ceRNA) network.

Methods

The researchers employed a bioinformatics approach to build a comprehensive ceRNA network. The core methodology involved:

  • Data Acquisition: Expression profiles of lncRNAs, miRNAs, and mRNAs were obtained from the Gene Expression Omnibus (GEO) database.
  • Differential Expression Analysis: Statistical methods (EdgeR software and t-test) were used to identify significantly differentially expressed genes (DELs, DEMis, and DEMs) between PCOS and normal samples, with a focus on |fold change| > 2 and a false discovery rate (FDR) < 0.05.
  • Target Prediction: Computational tools like RNAhybrid and miRanda were used to predict lncRNA-miRNA interactions, while miRTarBase and miRWalk were employed for miRNA-mRNA interactions.
  • ceRNA Network Construction: The ceRNA theory was applied to build the lncRNA-miRNA-mRNA network. This involved identifying competition triplets where an mRNA and a lncRNA are targeted by the same miRNA and exhibit negative co-expression. The network was visualized using Cytoscape.
  • Functional Enrichment Analysis: Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed on the differentially expressed mRNAs (DEMs) within the network to understand their biological functions and associated pathways.
  • Topological Analysis: Hub nodes (genes with high connectivity) within the network were identified to pinpoint key regulatory molecules.

Datasets

The study utilized publicly available gene expression data from the National Biotechnology Information Gene Expression Comprehensive Center database (GEO). Specifically, the human miRNA real-time PCR array database (GSE37425) was downloaded. No new datasets were generated or introduced by the authors.

Key Insights and Ideas

  • ceRNA Network as a Key Regulator: The study strongly suggests that the intricate ceRNA network, involving lncRNAs, miRNAs, and mRNAs, plays a significant role in the development and progression of PCOS.
  • Identification of Key lncRNAs: The research successfully identified specific lncRNAs (NONHSAT123397, ENST00000564619, and NONHSAT077997) that exhibit high connectivity and are likely crucial players in PCOS pathogenesis.
  • Functional Pathways Implicated in PCOS: The analysis revealed that differentially expressed genes in PCOS are enriched in pathways related to maternal processes, embryonic development, steroid hormone signaling, TGF-β signaling, Type I diabetes mellitus, and glycolysis/gluconeogenesis. This highlights the multifaceted nature of PCOS beyond just reproductive issues.
  • Potential Biomarkers: The identified key lncRNAs are proposed as potential diagnostic biomarkers for PCOS, offering a new avenue for early detection and monitoring.

Key Results

  • The study identified a substantial number of differentially expressed RNAs: 1087 lncRNAs, 14 miRNAs, and 566 mRNAs in PCOS samples compared to normal controls.
  • Within the constructed ceRNA regulatory network, 410 lncRNAs, 11 miRNAs, and 185 mRNAs were found to be involved.
  • Functional enrichment analysis indicated that DEMs were significantly enriched in biological processes such as "response to maternal process involved in female pregnancy," "morphogenesis of embryonic epithelium," and "intracellular steroid hormone receptor signaling pathway."
  • KEGG pathway analysis highlighted the enrichment of pathways like "TGF-β signaling pathway," "Type I diabetes mellitus," and "glycolysis/gluconeogenesis."
  • The topological analysis identified NONHSAT123397, ENST00000564619, and NONHSAT077997 as key lncRNAs due to their high node degrees and numerous interactions within the network.

Limitations and Future Work

The authors acknowledge that the current study is based on bioinformatics analysis and has limitations. They state that the experimental data is not yet sufficient for a comprehensive understanding of the mechanisms of action of the identified key lncRNAs.

Future work proposed includes:

  • Experimental Validation: Conducting experiments, such as dual-luciferase assays and RNA immunoprecipitation (RIP) assays, to experimentally verify the identified ceRNA network and the roles of the key lncRNAs.
  • Clinical Correlation: Exploring the correlation between the expression of the identified key lncRNAs (NONHSAT123397, ENST00000564619, and NONHSAT077997) and clinical parameters of PCOS patients (e.g., age, clinical stage, survival time).
  • Functional Studies: Investigating the regulation of proliferation and metastasis in PCOS by these key lncRNAs.
  • Broader Sample Size: Collecting more clinical samples for future studies to enhance the robustness of the findings.

Summary updated

BibTeX
@article{li2021bioinformatics,
  author = {Yuanqi Li and Yong Tan},
  title = {{Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome}},
  journal = {Comput. Math. Methods Medicine},
  year = {2021},
  doi = {10.1155/2021/9988347},
}
Figure